Correlation Between VistaGen Therapeutics and EnGene Holdings
Can any of the company-specific risk be diversified away by investing in both VistaGen Therapeutics and EnGene Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining VistaGen Therapeutics and EnGene Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between VistaGen Therapeutics and enGene Holdings Common, you can compare the effects of market volatilities on VistaGen Therapeutics and EnGene Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in VistaGen Therapeutics with a short position of EnGene Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of VistaGen Therapeutics and EnGene Holdings.
Diversification Opportunities for VistaGen Therapeutics and EnGene Holdings
-0.3 | Correlation Coefficient |
Very good diversification
The 3 months correlation between VistaGen and EnGene is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding VistaGen Therapeutics and enGene Holdings Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on enGene Holdings Common and VistaGen Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on VistaGen Therapeutics are associated (or correlated) with EnGene Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of enGene Holdings Common has no effect on the direction of VistaGen Therapeutics i.e., VistaGen Therapeutics and EnGene Holdings go up and down completely randomly.
Pair Corralation between VistaGen Therapeutics and EnGene Holdings
Given the investment horizon of 90 days VistaGen Therapeutics is expected to under-perform the EnGene Holdings. But the stock apears to be less risky and, when comparing its historical volatility, VistaGen Therapeutics is 2.78 times less risky than EnGene Holdings. The stock trades about -0.02 of its potential returns per unit of risk. The enGene Holdings Common is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 766.00 in enGene Holdings Common on August 26, 2024 and sell it today you would earn a total of 2.00 from holding enGene Holdings Common or generate 0.26% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
VistaGen Therapeutics vs. enGene Holdings Common
Performance |
| Timeline |
| VistaGen Therapeutics |
| enGene Holdings Common |
VistaGen Therapeutics and EnGene Holdings Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with VistaGen Therapeutics and EnGene Holdings
The main advantage of trading using opposite VistaGen Therapeutics and EnGene Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if VistaGen Therapeutics position performs unexpectedly, EnGene Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in EnGene Holdings will offset losses from the drop in EnGene Holdings' long position.| VistaGen Therapeutics vs. Synlogic | VistaGen Therapeutics vs. AC Immune | VistaGen Therapeutics vs. Histogen | VistaGen Therapeutics vs. Entera Bio |
| EnGene Holdings vs. Beam Therapeutics | EnGene Holdings vs. Caribou Biosciences | EnGene Holdings vs. Intellia Therapeutics | EnGene Holdings vs. Sana Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |